Results 71 to 80 of about 207,382 (216)

Der EbM+Theory Ansatz

Monitor Versorgungsforschung
Holger Pfaff und Jochen Schmitt greifen in ihrem „EbM+Theory Approach“ (2021 und 2023) Fragen der Evidencebasierung von Entscheidungen auf, die die evidenzbasierte Versorgungsforschung vor 30 Jahren bearbeitete.
Prof. em. Dr. phil. habil. Johann Behrens
doaj   +1 more source

Common illness backache : new ways of looking at [PDF]

, 2006
Ziel des Seminars war es, für die "Volkskrankheit Rückenschmerz" vom sportorthopädisch-traumatologisch-sportmedizinischen, vom internistischen, vom schmerztherapeutisch-neurochirurgischen und vom physiotherapeutischen Standpunkt aus neue, auf ...
Hoffmann, Gerd, Siegfried, Ingeborg
core  

Reply to Cooper and Stanojevic: ‘Is lung function in a race against time?’

Experimental Physiology, EarlyView.
Samuel Wallbanks
wiley   +1 more source

Simulation der Auswirkungen eines edukativen und digitalen Ansatzes unter Verwendung von Patient‐Journey‐Modellen, um praktische Herausforderungen bei der Behandlung der chronischen spontanen Urtikaria in Deutschland zu bewältigen

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 3, Page 338-348, March 2026.
Zusammenfassung Hintergrund und Zielsetzung Trotz verfügbarer Leitlinien und effektiver Eskalationstherapien wird die chronisch spontane Urtikaria (CSU) in Deutschland häufig unzureichend behandelt. Implementation Science kann helfen, evidenzbasierte Versorgung in die Praxis zu überführen.
Ralph von Kiedrowski, Mark Berneburg, Mona Biermann, Hanna Bonnekoh, Michael Fritz, Max Tischler, Martin Metz, Sebastian Volc, Nicola Wagner, Alexander Zink, Petra Nathan   +10 more
wiley   +1 more source

Feasibility and morbidity of combined hyperthermia and radiochemotherapy in recurrent rectal cancer - Preliminary results [PDF]

, 2003
Background: The local recurrence rate of colorectal cancer has been significantly reduced due to the use of combined radiochemotherapy. Despite this improvement regarding locally advanced tumour recurrences, the treatment strategy for pre-treated ...
Abdel-Rahman, Sultan, Dühmke, Eckhart, Ertl-Wagner, Birgit, Issels, Rolf-Dieter, Krych, M., Pachmann, S., Schaffer, Moshe, Schaffer, Pamela Manuela   +7 more
core   +1 more source

P1104: THE PROGNOSTIC ROLE OF DEPTH OF RESPONSE DEPENDS ON THE TIME OF ASSESSMENT AFTER FIRST-LINE IMMUNOCHEMOTHERAPY IN PATIENTS WITH SYMPTOMATIC WALDENSTROM MACROGOBULINEMIA (WM).

HemaSphere, 2023
Lydia Montes, Caroline Delette, Daniela Robu, Delphine Lebon, Etienne Paubelle, Jean Pierre Marolleau, Pierre Morel   +6 more
doaj   +1 more source

La donna e la medicina nella fiaba

Italies, 2023
Cette contribution vise à explorer le territoire délimité par l’intersection des mots « médecine », « maladie », « soin » et « femme » dans les Fiabe italiane d’Italo Calvino, en suivant la perspective donnée par la « médecine narrative » et en nous ...
Elisabetta Orlandi
doaj  

Gene Therapy and Modification as a Therapeutic Strategy for Cancer

University of Ottawa Journal of Medicine, 2016
Gene therapy is an exciting new field of personalized medicine, allowing for medical procedures that can target diseases such as cancer in novel ways. Technologies that involve gene transfer treatments allow for the insertion of foreign DNA into tumour ...
Ahsen Tahir Chaudhry, Daud Akhtar
doaj   +1 more source

Trastuzumab (Herceptin (R)): Monoclonal antibody in the treatment of HER2/neu-overexpressing breast cancer in the metastatic and (neo)adjuvant situation [PDF]

, 2006
Trastuzumab (Herceptin (R)) is a humanized monoclonal antibody that specifically targets HER2/neu (human epidermal growth factor receptor-2) breast cancer cells, which are overexpressed in about 25-30% of breast carcinomas.
Bauerfeind, Ingo, Ditsch, Nina, Friese, Klaus, Kahlert, Steffen, Kümper, Carolin, Lenhard, Miriam, Rückert, Sandra, Untch, Michael   +7 more
core   +2 more sources

GLUCOCORTICOID THERAPY

Medicine, 1976
1. There is a poor relationship between the circulating half-life a glucocorticoid and either its potency or its duration of action. Many actions of a glucocorticoid have unequal durations. The duration of action varies with the dose. 2. The presence of biological activity as a glucocorticoid depends on the presence of a hydroxyl group at carbon number
openaire   +2 more sources